Enovis (NYSE:ENOV) versus Gorman-Rupp (NYSE:GRC) Head-To-Head Contrast - Defense World

2022-05-13 21:38:08 By : Mr. Alfred Wang

Posted by admin on May 8th, 2022

Gorman-Rupp (NYSE:GRC – Get Rating) and Enovis (NYSE:ENOV – Get Rating) are both industrial products companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, dividends, valuation and earnings.

This table compares Gorman-Rupp and Enovis’ net margins, return on equity and return on assets.

This is a breakdown of recent recommendations for Gorman-Rupp and Enovis, as reported by MarketBeat.

Gorman-Rupp presently has a consensus target price of $46.00, suggesting a potential upside of 49.45%. Given Gorman-Rupp’s higher possible upside, equities analysts plainly believe Gorman-Rupp is more favorable than Enovis.

This table compares Gorman-Rupp and Enovis’ top-line revenue, earnings per share and valuation.

Enovis has higher revenue and earnings than Gorman-Rupp. Gorman-Rupp is trading at a lower price-to-earnings ratio than Enovis, indicating that it is currently the more affordable of the two stocks.

55.9% of Gorman-Rupp shares are held by institutional investors. 7.2% of Gorman-Rupp shares are held by insiders. Comparatively, 8.2% of Enovis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Gorman-Rupp has a beta of 0.62, indicating that its stock price is 38% less volatile than the S&P 500. Comparatively, Enovis has a beta of 2.2, indicating that its stock price is 120% more volatile than the S&P 500.

Gorman-Rupp beats Enovis on 7 of the 13 factors compared between the two stocks.

The Gorman-Rupp Company designs, manufactures, and sells pumps and pump systems in the United States and internationally. The company's products include self-priming centrifugal, standard centrifugal, magnetic drive centrifugal, axial and mixed flow, vertical turbine line shaft, submersible, high pressure booster, rotary gear, diaphragm, bellows, and oscillating pumps. Its products are used in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, military, and other liquid-handling applications, as well as in heating, ventilating, and air conditioning applications. The company markets its products through a network of distributors, manufacturers' representatives, third-party distributor catalogs, direct sales, and commerce. The Gorman-Rupp Company was founded in 1933 and is headquartered in Mansfield, Ohio.

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

Receive News & Ratings for Gorman-Rupp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gorman-Rupp and related companies with MarketBeat.com's FREE daily email newsletter.

$600,000.00 in Sales Expected for Oncternal Therapeutics, Inc. (NASDAQ:ONCT) This Quarter

Zoom Video Communications (NASDAQ:ZM) versus DouYu International (NASDAQ:DOYU) Financial Comparison